Expression of p21ras-related protein in the plasma and tissue of patients with adenomas and carcinomas of the colon.

Abstract Over-expression of p21 ras-related protein was determined in the plasma by immunoblotting and in the tissue by immuno-histochemistry in a cohort of patients undergoing colonoscopy. In the plasma samples, p21 ras over-expression was detected in: 9% (4/47) of normal controls; 21% (13/61) of individuals with normal colonoscopies but with a prior history of colonic neoplasia; 12% (4/33) of small adenoma patients, 29% (6/21) of large adenoma patients; 63% (5/8) of carcinoma-in-adenoma patients; 50% (2/4) of Dukes' A carcinoma patients; and 20% (2/10) of Dukes' B-D carcinoma patients. In the tissue samples, p21 ras over-expression was detected in: 25% (2/8) of small adenoma patients; 44% (4/9) of large adenoma patients; 100% (4/4) of carcinoma-in-adenoma patients; and 33% (1/3) of Dukes' B-C carcinoma patients. For matched plasma-tissue pairs, there was a statistically significant correlation for p21 ras over-expression (R = 0.47, p = 0.02).

[1]  A. Neugut,et al.  Levels of p53 antigen in the plasma of patients with adenomas and carcinomas of the colon. , 1995, Cancer letters.

[2]  A. Szporn,et al.  ras and c-myc protein expression in colorectal carcinoma , 1992, Diseases of the colon and rectum.

[3]  K. Hemminki,et al.  Serum oncoproteins and growth factors in asbestosis and silicosis patients , 1992, International journal of cancer.

[4]  P. Brandt-rauf.  Oncogene proteins as biomarkers in the molecular epidemiology of occupational carcinogenesis , 1991, International archives of occupational and environmental health.

[5]  P. Brandt-Rauf,et al.  Correlation between Serum Oncogene Protein Expression and the Development of Neoplastic Disease in a Worker Exposed to Carcinogens , 1990, Journal of the Royal Society of Medicine.

[6]  J. Schlom,et al.  An immunohistochemical analysis of ras oncogene expression in epithelial neoplasms of the colon , 1990, Cancer.

[7]  D. Spandidos,et al.  Ras p21 onco-protein in the sera of mice carrying an experimentally induced tumor and in human cancer patients. , 1990, In vivo.

[8]  G. Lanza.  ras p21 oncoprotein expression in human colonic neoplasia—an immunohistochemical study with monoclonal antibody RAP‐5 , 1988, Histopathology.

[9]  J. Schlom,et al.  Absolute values of ras p21 defined by direct binding liquid competition radioimmunoassays. , 1987, Biochimica et biophysica acta.

[10]  R. Kurzrock,et al.  Expression of p21ras in fresh primary and metastatic human colorectal tumors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Hand,et al.  Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases , 1984, Nature.

[12]  J. Weissfeld,et al.  Evaluation of oncogene-related proteins in serum. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  F. Perera,et al.  Molecular and genetic damage in humans from environmental pollution in Poland , 1993, Nature.

[14]  A. Bartal,et al.  Competitive ELISA for detection of native ras gene‐related products in sera of cancer patients , 1989, Journal of clinical laboratory analysis.